• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Johnson & Johnson

Johnson & Johnson

Johnson & Johnson JNJ

Last Price$112.08Day Change (%)-0.36%
Open Price$112.06Day Change ($)-0.40
Day Range111.51–112.2252-Week Range81.79–114.19

As of Fri 4/29/2016 7:06:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: What to expect from Johnson & Johnson's earnings

    UPDATE: What to expect from Johnson & Johnson's earnings

  2. UPDATE: What to expect from Johnson & Johnson's earnings

    UPDATE: What to expect from Johnson & Johnson's earnings

  3. European CHMP Adopts Positive Opinion for Gilead’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIV

    European CHMP Adopts Positive Opinion for Gilead’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIV

  4. 6 Dow stocks have hit record intraday highs this week

    6 Dow stocks have hit record intraday highs this week

  5. UPDATE: Broadening sector participation -2-

    UPDATE: Broadening sector participation -2-

  6. UPDATE: Broadening sector participation signals bull trend has room to run

    UPDATE: Broadening sector participation signals bull trend has room to run

  7. UPDATE: Why a deluge of weak earnings won't derail the U.S. stock market

    UPDATE: Why a deluge of weak earnings won't derail the U.S. stock market

  8. MARKET SNAPSHOT: Why A Deluge Of Weak Earnings Won't Derail The U.S. Stock Market

    MARKET SNAPSHOT: Why A Deluge Of Weak Earnings Won't Derail The U.S. Stock Market

  9. MARKET SNAPSHOT: Why Tepid Earnings Reports Aren't Hurting Stocks

    MARKET SNAPSHOT: Why Tepid Earnings Reports Aren't Hurting Stocks

  10. UPDATE: Why tepid earnings reports aren't hurting stocks

    UPDATE: Why tepid earnings reports aren't hurting stocks

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.